You now have access to all the content in the PAREXEL Access Hub. We look forward to engaging with you.
We will be in touch shortly.
Please complete our registration form to continue.
Recently, many sponsors have experienced rising demand from regulators and payers to carry out cardiovascular outcomes trials (CVOT), not only for mandated for type 2 diabetes products but increasingly for other diseases and indications. This infographic addresses some of the frequently asked questions surrounding CVOTs presented from a former Cardiovascular Safety Outcome Trials Think Tank Meeting.
Have you considered:
Regulatory & Payer Submissions